IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity.
Authors
Molgora, MBonavita, E
Ponzetta, A
Riva, F
Barbagallo, M
Jaillon, S
Popović, B
Bernardini, G
Magrini, E
Gianni, F
Zelenay, Santiago
Jonjić, S
Santoni, A
Garlanda, C
Mantovani, A
Affiliation
Humanitas Clinical and Research Center, 20089 Rozzano, ItalyIssue Date
2017-11-02
Metadata
Show full item recordAbstract
Interleukin-1 receptor 8 (IL-1R8, also known as single immunoglobulin IL-1R-related receptor, SIGIRR, or TIR8) is a member of the IL-1 receptor (ILR) family with distinct structural and functional characteristics, acting as a negative regulator of ILR and Toll-like receptor (TLR) downstream signalling pathways and inflammation. Natural killer (NK) cells are innate lymphoid cells which mediate resistance against pathogens and contribute to the activation and orientation of adaptive immune responses. NK cells mediate resistance against haematopoietic neoplasms but are generally considered to play a minor role in solid tumour carcinogenesis. Here we report that IL-1R8 serves as a checkpoint for NK cell maturation and effector function. Its genetic blockade unleashes NK-cell-mediated resistance to hepatic carcinogenesis, haematogenous liver and lung metastasis, and cytomegalovirus infection.Citation
IL-1R8 is a checkpoint in NK cells regulating anti-tumour and anti-viral activity. 2017, 551(7678): 110-114 NatureJournal
NatureDOI
10.1038/nature24293PubMed ID
29072292Type
ArticleLanguage
enISSN
1476-4687ae974a485f413a2113503eed53cd6c53
10.1038/nature24293
Scopus Count
Collections
Related articles
- IL-1R8: A molecular brake of anti-tumor and anti-viral activity of NK cells and ILC.
- Authors: Mariotti FR, Supino D, Landolina N, Garlanda C, Mantovani A, Moretta L, Maggi E
- Issue date: 2023 Mar
- Tuning inflammation and immunity by the negative regulators IL-1R2 and IL-1R8.
- Authors: Molgora M, Supino D, Mantovani A, Garlanda C
- Issue date: 2018 Jan
- High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity.
- Authors: Campesato LF, Silva APM, Cordeiro L, Correa BR, Navarro FCP, Zanin RF, Marçola M, Inoue LT, Duarte ML, Molgora M, Pasqualini F, Massara M, Galante P, Barroso-Sousa R, Polentarutti N, Riva F, Costa ET, Mantovani A, Garlanda C, Camargo AA
- Issue date: 2017 Jul 25
- Cmv1-independent antiviral role of NK cells revealed in murine cytomegalovirus-infected New Zealand White mice.
- Authors: Rodriguez M, Sabastian P, Clark P, Brown MG
- Issue date: 2004 Nov 15
- Ly49H engagement compensates for the absence of type I interferon signaling in stimulating NK cell proliferation during murine cytomegalovirus infection.
- Authors: Geurs TL, Zhao YM, Hill EB, French AR
- Issue date: 2009 Nov 1